HomeOBI • LON
add
Ondine Biomedical Inc
Previous close
GBX 8.25
Year range
GBX 5.50 - GBX 13.30
Market cap
36.61M GBP
Avg Volume
128.18K
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 595.00K | 53.55% |
Operating expense | 6.20M | 71.66% |
Net income | -5.67M | -74.08% |
Net profit margin | -952.61 | -13.37% |
Earnings per share | — | — |
EBITDA | -5.75M | -72.19% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 9.77M | 227.64% |
Total assets | 12.82M | 123.61% |
Total liabilities | 5.94M | 62.92% |
Total equity | 6.88M | — |
Shares outstanding | 307.73M | — |
Price to book | 4.12 | — |
Return on assets | -113.22% | — |
Return on capital | -206.07% | — |
Cash Flow
Net change in cash
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -5.67M | -74.08% |
Cash from operations | -4.20M | -53.42% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 8.23M | 311.71% |
Net change in cash | 4.28M | 690.88% |
Free cash flow | -3.74M | -98.93% |
About
Founded
1996
Headquarters
Website
Employees
43
